Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1117-1122
Published online before print April 10, 2008, doi: 10.1161/ATVBAHA.108.165589
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/6/1117    most recent
ATVBAHA.108.165589v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chappell, J. C.
Right arrow Articles by Price, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chappell, J. C.
Right arrow Articles by Price, R. J.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1117.)
© 2008 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Ultrasonic Microbubble Destruction Stimulates Therapeutic Arteriogenesis Via the CD18-Dependent Recruitment of Bone Marrow–Derived Cells

John C. Chappell; Ji Song; Alexander L. Klibanov; Richard J. Price

From the Department of Biomedical Engineering (J.C.C., J.S., R.J.P.) and the Cardiovascular Division (A.L.K.), University of Virginia, Charlottesville.

Correspondence to Richard J. Price, PhD, Associate Professor, Department of Biomedical Engineering, University of Virginia, Box 800759, UVA Health System, Charlottesville, VA 22908. E-mail rprice{at}virginia.edu

Objective— We have previously shown that, under certain conditions, ultrasonic microbubble destruction creates arteriogenesis and angiogenesis in skeletal muscle. Here, we tested whether this neovascularization response enhances hyperemia in a rat model of arterial insufficiency and is dependent on the recruitment of bone marrow–derived cells (BMDCs) to treated tissues via a β2 integrin (CD18)-dependent mechanism.

Methods and Results— Sprague-Dawley rats, C57BL/6 wild-type mice, and C57BL/6 chimeric mice engrafted with BMDCs from either GFP+ or CD18–/– mice received bilateral femoral artery ligations. Microbubbles (MBs) were intravenously injected, and one gracilis muscle was exposed to pulsed 1 MHz ultrasound (US). Rat hindlimbs exhibited significant increases in adenosine-induced hyperemia and arteriogenesis compared to contralateral controls at 14 and 28 days posttreatment. US-MB–treated wild-type C57BL/6 mice exhibited significant arteriogenesis, angiogenesis, and CD11b+ monocyte recruitment; however, these responses were all completely blocked in CD18–/– chimeric mice. The number of BMDCs increased in US-MB–treated muscles of GFP+ chimeric mice; however, GFP+ BMDCs did not incorporate into microvessels as vascular cells.

Conclusion— In skeletal muscle affected by arterial occlusion, arteriogenesis and hyperemia can be significantly enhanced by ultrasonic MB destruction. This response depends on the recruitment, but not vascular incorporation, of BMDCs via a CD18-dependent mechanism.

Ultrasonic microbubble destruction represents a potential tool in therapeutic strategies, particularly in the targeted stimulation of neovascularization. In the current study, we demonstrate the ability of ultrasound-microbubble interactions to enhance arteriogenesis and perfusion in ischemic tissues through recruitment of marrow-derived cells via CD18. These observations support the development of ultrasound microbubble–based therapies.


Key Words: ultrasonics • contrast media • arteriogenesis • microcirculation • marrow-derived cells




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. M. Nickerson, J. Song, J. K. Meisner, S. Bajikar, C. W. Burke, C. W. Shuptrine, G. K. Owens, T. C. Skalak, and R. J. Price
Bone Marrow-Derived Cell-Specific Chemokine (C-C Motif) Receptor-2 Expression is Required for Arteriolar Remodeling
Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1794 - 1801.
[Abstract] [Full Text] [PDF]